Literature DB >> 20815813

Regulation of the tumour suppressor Fbw7α by PKC-dependent phosphorylation and cancer-associated mutations.

Joanne Durgan1, Peter J Parker.   

Abstract

Fbw7 (F-box WD40 protein 7) is a major tumour suppressor, which mediates the degradation of several potent oncogenes. PKC (protein kinase C) comprises a serine/threonine kinase family that can promote transformation when dysregulated. In the present study, we investigated the relationship between Fbw7 and PKC. Multiple members of the PKC superfamily interact with the substrate-binding domain of Fbw7. However, we find no evidence for Fbw7-mediated degradation of PKC. Instead, we demonstrate that Fbw7 is a novel substrate for PKC. Two residues within the isoform-specific N-terminus of Fbw7α are phosphorylated in a PKC-dependent manner, both in vitro and in mammalian cells (Ser¹⁰ and Ser¹⁸). Mutational analyses reveal that phosphorylation of Fbw7α at Ser10 can regulate its nuclear localization. Cancer-associated mutations in nearby residues (K11R and the addition of a proline residue at position 16) influence Fbw7α localization in a comparable manner, suggesting that mislocalization of this protein may be of pathological significance. Together these results provide evidence for both physical and functional interactions between the PKC and Fbw7 families, and yield insights into the isoform-specific regulation of Fbw7α.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20815813     DOI: 10.1042/BJ20100799

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing program.

Authors:  Edward F Attiyeh; John M Maris; Richard Lock; C Patrick Reynolds; Min H Kang; Hernan Carol; Richard Gorlick; E Anders Kolb; Stephen T Keir; Jianrong Wu; Yosef Landesman; Sharon Shacham; Dmitry Lyalin; Raushan T Kurmasheva; Peter J Houghton; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2015-09-23       Impact factor: 3.167

2.  The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function.

Authors:  Veronika Reiterer; Cristina Figueras-Puig; Francois Le Guerroue; Stefano Confalonieri; Manuela Vecchi; Dasaradha Jalapothu; Sandip M Kanse; Raymond J Deshaies; Pier Paolo Di Fiore; Christian Behrends; Hesso Farhan
Journal:  EMBO J       Date:  2016-12-22       Impact factor: 11.598

Review 3.  Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.

Authors:  Liangliang Xing; Leidi Xu; Yong Zhang; Yinggang Che; Min Wang; Yongxiang Shao; Dan Qiu; Honglian Yu; Feng Zhao; Jian Zhang
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

4.  PKCε contributes to lipid-induced insulin resistance through cross talk with p70S6K and through previously unknown regulators of insulin signaling.

Authors:  Brandon M Gassaway; Max C Petersen; Yulia V Surovtseva; Karl W Barber; Joshua B Sheetz; Hans R Aerni; Jane S Merkel; Varman T Samuel; Gerald I Shulman; Jesse Rinehart
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

Review 5.  Physiological functions of FBW7 in cancer and metabolism.

Authors:  Kouhei Shimizu; Naoe Taira Nihira; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Cell Signal       Date:  2018-02-21       Impact factor: 4.315

Review 6.  Function and regulation of F-box/WD repeat-containing protein 7.

Authors:  Zheng Zhang; Qiangsheng Hu; Wenyan Xu; Wensheng Liu; Mengqi Liu; Qiqing Sun; Zeng Ye; Guixiong Fan; Yi Qin; Xiaowu Xu; Xianjun Yu; Shunrong Ji
Journal:  Oncol Lett       Date:  2020-06-11       Impact factor: 2.967

7.  Ehrlichia chaffeensis TRP120-mediated ubiquitination and proteasomal degradation of tumor suppressor FBW7 increases oncoprotein stability and promotes infection.

Authors:  Jennifer Y Wang; Bing Zhu; LaNisha L Patterson; Madison R Rogan; Clayton E Kibler; Jere W McBride
Journal:  PLoS Pathog       Date:  2020-04-30       Impact factor: 6.823

8.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.

Authors:  Yeong Jun Kim; Yuri Kim; Abhishek Kumar; Chan Woo Kim; Zsolt Toth; Nam Hyuk Cho; Hye-Ra Lee
Journal:  PLoS Pathog       Date:  2021-01-20       Impact factor: 6.823

9.  The stability of Fbw7α in M-phase requires its phosphorylation by PKC.

Authors:  Sihem Zitouni; Francisca Méchali; Catherine Papin; Armelle Choquet; Daniel Roche; Véronique Baldin; Olivier Coux; Catherine Bonne-Andrea
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240

Review 10.  FBXW7: a critical tumor suppressor of human cancers.

Authors:  Chien-Hung Yeh; Marcia Bellon; Christophe Nicot
Journal:  Mol Cancer       Date:  2018-08-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.